Pharma Delivery and Supply Chain

Vector Science & Therapeutics announces cGMP manufacturing agreement with LyoGenesis Plus for its proprietary peptide portfolio

Vector Science & Therapeutics Chas entered an exclusive licensing and manufacturing agreement with LyoGenesis Plus, a cGMP lyophilisation and manufacturing partner based in Mequon,...

Reacta Healthcare receives extended MHRA pharmaceutical manufacturer’s licence and GMP certificate

Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, has had its manufacturer’s licence and...

Deora from Stevanato, a new proprietary pen injector platform targeting incretin-based therapies

Stevanato Group, a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, has introduced...

Reacta Healthcare receives extended MHRA pharmaceutical manufacturer’s licence and GMP certificate

Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, has had its manufacturer’s licence and...

Reprocell submits application for manufacturing and marketing approval in Japan for stem cell therapy Stemchymal for spinocerebellar ataxia

Reprocell has submitted an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal®, for which the company holds exclusive...

Alcami to acquire contract packaging organisation Tjoapack

Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire Tjoapack, a leading global contract...

Alcami to acquire contract packaging organisation Tjoapack

Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire Tjoapack, a leading global contract...

PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities

PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Latest stories